Literature DB >> 27865749

In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.

Asa Rahimi1, Gursev Anmole2, Maribel Soto-Nava3, Tania Escamilla-Gomez3, Tristan Markle2, Steven W Jin2, Guinevere Q Lee4, P Richard Harrigan4, David R Bangsberg5, Jeffrey Martin6, Santiago Avila-Rios3, Gustavo Reyes-Teran3, Mark A Brockman7, Zabrina L Brumme8.   

Abstract

The HIV-1 accessory protein Vpu exhibits high inter- and intra- subtype genetic diversity that may influence Vpu function and possibly contribute to HIV-1 pathogenesis. However, scalable methods to evaluate genotype/phenotype relationships in natural Vpu sequences are limited, particularly those expressing the protein in CD4+ T-cells, the natural target of HIV-1 infection. A major impediment to assay scalability is the extensive genetic diversity within, and immediately upstream of, Vpu's initial 5' coding region, which has necessitated the design of oligonucleotide primers specific for each individual HIV-1 isolate (or subtype). To address this, we developed two universal forward primers, located in relatively conserved regions 38 and 90 bases upstream of Vpu, and a single universal reverse primer downstream of Vpu, which are predicted to cover the vast majority of global HIV-1 group M sequence diversity. We show that inclusion of up to 90 upstream bases of HIV-1 genomic sequence does not significantly influence in vitro Vpu expression or function when a Rev/Rev Response Element (RRE)-dependent expression system is used. We further assess the function of four diverse HIV-1 Vpu sequences, revealing reproducible and significant differences between them. Our approach represents a scalable option to measure the in vitro function of genetically diverse natural Vpu isolates in a CD4+ T-cell line.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BST2/tetherin; CD4; Downregulation; HIV-1 Vpu; Rev/RRE; Sequence diversity

Mesh:

Substances:

Year:  2016        PMID: 27865749      PMCID: PMC5183569          DOI: 10.1016/j.jviromet.2016.11.004

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  42 in total

1.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

Authors:  Ankur H Shah; Bharatwaj Sowrirajan; Zachary B Davis; Jeffrey P Ward; Edward M Campbell; Vicente Planelles; Edward Barker
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

2.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana.

Authors:  T Ndung'u; B Renjifo; V A Novitsky; M F McLane; S Gaolekwe; M Essex
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

5.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.

Authors:  J Lama; A Mangasarian; D Trono
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

6.  Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Authors:  Andre J Marozsan; Dawn M Moore; Michael A Lobritz; Erika Fraundorf; Awet Abraha; Jacqueline D Reeves; Eric J Arts
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.

Authors:  Janet L Douglas; Ying Bai; Jean K Gustin; Ashlee V Moses
Journal:  Virology       Date:  2013-04-10       Impact factor: 3.616

8.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

9.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

10.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

Authors:  Robert C Edgar
Journal:  BMC Bioinformatics       Date:  2004-08-19       Impact factor: 3.169

View more
  5 in total

1.  Patterns of genomic site inheritance in HIV-1M inter-subtype recombinants delineate the most likely genomic sites of subtype-specific adaptation.

Authors:  Marcel Tongo; Tulio de Oliveira; Darren P Martin
Journal:  Virus Evol       Date:  2018-06-11

2.  Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors.

Authors:  Gisele Umviligihozo; Jaclyn K Mann; Steven W Jin; Francis M Mwimanzi; Hua-Shiuan A Hsieh; Hanwei Sudderuddin; Guinevere Q Lee; Helen Byakwaga; Conrad Muzoora; Peter W Hunt; Jeff N Martin; Jessica E Haberer; Etienne Karita; Susan Allen; Eric Hunter; Zabrina L Brumme; Mark A Brockman
Journal:  Front Virol       Date:  2022-06-16

3.  Unravelling the complicated evolutionary and dissemination history of HIV-1M subtype A lineages.

Authors:  Marcel Tongo; Gordon W Harkins; Jeffrey R Dorfman; Erik Billings; Sodsai Tovanabutra; Tulio de Oliveira; Darren P Martin
Journal:  Virus Evol       Date:  2018-02-19

4.  Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.

Authors:  Zabrina L Brumme; Mark A Brockman; Gisele Umviligihozo; Kyle D Cobarrubias; Sandali Chandrarathna; Steven W Jin; Nicole Reddy; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Guinevere Q Lee; Peter W Hunt; Jeff N Martin; Chanson J Brumme; David R Bangsberg; Etienne Karita; Susan Allen; Eric Hunter; Thumbi Ndung'u
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

5.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.

Authors:  Nathaniel D Bachtel; Gisele Umviligihozo; Suzanne Pickering; Talia M Mota; Hua Liang; Gregory Q Del Prete; Pramita Chatterjee; Guinevere Q Lee; Rasmi Thomas; Mark A Brockman; Stuart Neil; Mary Carrington; Bosco Bwana; David R Bangsberg; Jeffrey N Martin; Esper G Kallas; Camila S Donini; Natalia B Cerqueira; Una T O'Doherty; Beatrice H Hahn; R Brad Jones; Zabrina L Brumme; Douglas F Nixon; Richard Apps
Journal:  PLoS Pathog       Date:  2018-09-04       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.